{"transactions":[{"id":732062,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T21:28:46.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2027 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2029. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":50000,"derivative":{"exercise_price":9.42,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-26-276138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000119312526276138/ownership.xml","form_type":"4"}},{"id":946663,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-01-06T21:40:09.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."}],"balance_after":112500,"derivative":{"underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001608936-26-000002","document":"form4-01062026_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893626000002/form4-01062026_090105.xml","form_type":"4"}},{"id":946662,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:40:09.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":675000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001608936-26-000002","document":"form4-01062026_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893626000002/form4-01062026_090105.xml","form_type":"4"}},{"id":964984,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":66667,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":964983,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":28333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":28334,"derivative":{"underlying":"Common Stock","underlying_shares":28333},"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":964982,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":964981,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":33374,"price":9.06,"value":302368.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 33,374 shares sold in the price range of $9.0257 to $9.095 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":581711,"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":964980,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":83666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."}],"balance_after":615085,"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":1021409,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-10-08T21:35:33.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":37461,"price":12.32,"value":461519.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 37,461 shares sold in the price range of $12.07 to $12.59 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person also holds restricted stock units (RSUs) representing a contingent right to receive 178,667 shares of ORIC Pharmaceuticals, Inc. Common Stock and stock options to purchase 3,378,000 shares of ORIC Pharmaceuticals, Inc. Common Stock, which were previously reported on Table II and are not included in this number."}],"balance_after":531419,"source":{"system":"sec-edgar","filing":"0001608936-25-000010","document":"form4-10082025_091029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000010/form4-10082025_091029.xml","form_type":"4"}},{"id":1027169,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-10-02T23:18:37.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":53001,"price":12.0527,"value":638805.1527,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 53,001 shares sold in the price range of $12.00 to $12.13 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person also holds restricted stock units (RSUs) representing a contingent right to receive 178,667 shares of ORIC Pharmaceuticals, Inc. Common Stock and stock options to purchase 3,378,000 shares of ORIC Pharmaceuticals, Inc. Common Stock, which were previously reported on Table II and are not included in this number."}],"balance_after":568880,"source":{"system":"sec-edgar","filing":"0001608936-25-000008","document":"form4-10022025_111028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000008/form4-10022025_111028.xml","form_type":"4"}},{"id":1027168,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-10-02T23:18:37.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":34538,"price":12.0085,"value":414749.573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 34,538 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person also holds restricted stock units (RSUs) representing a contingent right to receive 178,667 shares of ORIC Pharmaceuticals, Inc. Common Stock and stock options to purchase 3,378,000 shares of ORIC Pharmaceuticals, Inc. Common Stock, which were previously reported on Table II and are not included in this number."}],"balance_after":621881,"source":{"system":"sec-edgar","filing":"0001608936-25-000008","document":"form4-10022025_111028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000008/form4-10022025_111028.xml","form_type":"4"}},{"id":1033016,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-09-24T20:30:20.000Z","date":"2025-09-22","kind":"sale","planned":true,"acquired":false,"shares":125000,"price":10.7995,"value":1349937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 125,000 shares sold in the price range of $10.57 to $10.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,771 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person also holds restricted stock units (RSUs) representing a contingent right to receive 178,667 shares of ORIC Pharmaceuticals, Inc. Common Stock and stock options to purchase 3,378,000 shares of ORIC Pharmaceuticals, Inc. Common Stock, which were previously reported on Table II and are not included in this number."}],"balance_after":656419,"source":{"system":"sec-edgar","filing":"0001608936-25-000006","document":"form4-09242025_080916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000006/form4-09242025_080916.xml","form_type":"4"}},{"id":1104989,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:05:35.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2026 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2028. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":4.15,"expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-25-088497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000095017025088497/ownership.xml","form_type":"4"}},{"id":1314679,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-01-03T22:41:01.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-000600","document":"form4-01032025_100156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588925000600/form4-01032025_100156.xml","form_type":"4"}},{"id":1314678,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:41:01.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":600000,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001415889-25-000600","document":"form4-01032025_100156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588925000600/form4-01032025_100156.xml","form_type":"4"}},{"id":1328561,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:21:01.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":28333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":56667,"derivative":{"underlying":"Common Stock","underlying_shares":28333},"source":{"system":"sec-edgar","filing":"0001415889-24-029631","document":"form4-12172024_101258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588924029631/form4-12172024_101258.xml","form_type":"4"}},{"id":1328560,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:21:01.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":22000,"derivative":{"underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001415889-24-029631","document":"form4-12172024_101258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588924029631/form4-12172024_101258.xml","form_type":"4"}},{"id":1328559,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:21:01.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001415889-24-029631","document":"form4-12172024_101258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588924029631/form4-12172024_101258.xml","form_type":"4"}},{"id":1328558,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-17T22:21:01.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":24660,"price":8.2812,"value":204214.392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 24,660 shares sold in the price range of $8.27 to $8.39 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":778648,"source":{"system":"sec-edgar","filing":"0001415889-24-029631","document":"form4-12172024_101258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588924029631/form4-12172024_101258.xml","form_type":"4"}},{"id":1328557,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-17T22:21:01.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":803308,"source":{"system":"sec-edgar","filing":"0001415889-24-029631","document":"form4-12172024_101258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588924029631/form4-12172024_101258.xml","form_type":"4"}},{"id":1503641,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right To Buy)","published_at":"2024-05-23T23:17:27.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 21, 2025 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 21, 2027. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":25.15,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-24-064221","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000095017024064221/ownership.xml","form_type":"4"}},{"id":1586683,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-08T21:20:44.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":40000,"price":16.2095,"value":648380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $16.00 to $16.43 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":728544,"source":{"system":"sec-edgar","filing":"0001415889-24-007345","document":"form4-03082024_090337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588924007345/form4-03082024_090337.xml","form_type":"4"}},{"id":1653410,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-09T01:01:26.000Z","date":"2024-02-07","kind":"sale","planned":false,"acquired":false,"shares":26042,"price":12.295,"value":320186.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 26,042 shares sold in the price range of $12.11 to $12.40 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":768544,"source":{"system":"sec-edgar","filing":"0001415889-24-003114","document":"form4-02092024_010219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588924003114/form4-02092024_010219.xml","form_type":"4"}},{"id":1653409,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-09T01:01:26.000Z","date":"2024-02-06","kind":"sale","planned":false,"acquired":false,"shares":13958,"price":12.1192,"value":169159.7936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 13,958 shares sold in the price range of $12.00 to $12.31 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":794586,"source":{"system":"sec-edgar","filing":"0001415889-24-003114","document":"form4-02092024_010219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588924003114/form4-02092024_010219.xml","form_type":"4"}},{"id":1692381,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2024-01-03T21:17:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":85000,"derivative":{"underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-24-000361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919124000361/doc4.xml","form_type":"4"}},{"id":1692380,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T21:17:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":510000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2025, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":510000,"derivative":{"exercise_price":9.14,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":510000},"source":{"system":"sec-edgar","filing":"0001209191-24-000361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919124000361/doc4.xml","form_type":"4"}},{"id":1704812,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-12-20T00:39:10.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":44000,"derivative":{"underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-23-059263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123059263/doc4.xml","form_type":"4"}},{"id":1704811,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-12-20T00:39:10.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":16667,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001209191-23-059263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123059263/doc4.xml","form_type":"4"}},{"id":1704810,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-20T00:39:10.000Z","date":"2023-12-15","kind":"sale","planned":false,"acquired":false,"shares":14539,"price":8.5847,"value":124812.9533,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 14,539 shares sold in the price range of $8.57 to $8.77 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":808544,"source":{"system":"sec-edgar","filing":"0001209191-23-059263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123059263/doc4.xml","form_type":"4"}},{"id":1704809,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-20T00:39:10.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":38667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":823083,"source":{"system":"sec-edgar","filing":"0001209191-23-059263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123059263/doc4.xml","form_type":"4"}},{"id":1831609,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-12T01:28:18.000Z","date":"2023-07-11","kind":"sale","planned":false,"acquired":false,"shares":5156,"price":8.0076,"value":41287.1856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 5,156 shares sold in the price range of $8.00 to $8.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":780652,"source":{"system":"sec-edgar","filing":"0001209191-23-042054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123042054/doc4.xml","form_type":"4"}},{"id":1831608,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-12T01:28:18.000Z","date":"2023-07-10","kind":"sale","planned":false,"acquired":false,"shares":10508,"price":8.0141,"value":84212.1628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 10,508 shares sold in the price range of $8.00 to $8.05 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":785808,"source":{"system":"sec-edgar","filing":"0001209191-23-042054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123042054/doc4.xml","form_type":"4"}},{"id":1832895,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-07T20:35:17.000Z","date":"2023-07-05","kind":"sale","planned":false,"acquired":false,"shares":4336,"price":8.0052,"value":34710.5472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 4,336 shares sold in the price range of $8.00 to $8.025 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":796316,"source":{"system":"sec-edgar","filing":"0001209191-23-041805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123041805/doc4.xml","form_type":"4"}},{"id":1842678,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-28T23:18:56.000Z","date":"2023-06-26","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":8.0281,"value":160562.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $8.00 to $8.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 4,000 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":800652,"source":{"system":"sec-edgar","filing":"0001209191-23-040090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123040090/doc4.xml","form_type":"4"}},{"id":1878081,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-25T23:32:17.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2024 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2026. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":17.98,"expiration_date":"2033-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001610717-23-000068","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000161071723000068/form4.xml","form_type":"4"}},{"id":1914142,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-25T22:43:09.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."}],"balance_after":32500,"derivative":{"exercise_price":9.41,"expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-23-020315","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000114036123020315/form4.xml","form_type":"4"}},{"id":1914141,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-25T22:43:09.000Z","date":"2023-04-21","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":20.0539,"value":100269.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $20.00 to $20.23, inclusive. The price reported in Column 4 above reflects the weighted average sale\nprice. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full\ninformation regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-020315","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000114036123020315/form4.xml","form_type":"4"}},{"id":1914140,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-25T22:43:09.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":9.41,"value":47050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-23-020315","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000114036123020315/form4.xml","form_type":"4"}},{"id":2007572,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-17T21:22:44.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":6137,"price":3.073,"value":18859.001,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is filed to correct the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is filed to correct the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This amendment is filed to correct the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person."}],"balance_after":816652,"source":{"system":"sec-edgar","filing":"0001209191-23-010607","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123010607/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-16"}},{"id":2036067,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-02T21:09:57.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":66000,"derivative":{"underlying":"Common Stock","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001209191-23-006191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123006191/doc4.xml","form_type":"4"}},{"id":2036066,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T21:09:57.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":400000,"derivative":{"exercise_price":6,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-23-006191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919123006191/doc4.xml","form_type":"4"}},{"id":2083653,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-12-17T01:47:24.000Z","date":"2022-12-15","kind":"exercise","acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":33334,"derivative":{"underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001209191-22-061754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122061754/doc4.xml","form_type":"4"}},{"id":2083652,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-17T01:47:24.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":5764,"price":3.25,"value":18733.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."}],"balance_after":817025,"source":{"system":"sec-edgar","filing":"0001209191-22-061754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122061754/doc4.xml","form_type":"4"}},{"id":2083651,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-17T01:47:24.000Z","date":"2022-12-15","kind":"exercise","acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 3,471 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":822789,"source":{"system":"sec-edgar","filing":"0001209191-22-061754","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122061754/doc4.xml","form_type":"4"}},{"id":2203932,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:05:48.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty five percent (25%) of the shares subject to the option shall vest on July 20, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":300000,"derivative":{"exercise_price":4.36,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-22-042841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122042841/doc4.xml","form_type":"4"}},{"id":2203931,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:05:48.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":280000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Twenty five percent (25%) of the shares subject to the option shall vest on July 20, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":280000,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001209191-22-042841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122042841/doc4.xml","form_type":"4"}},{"id":2203930,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:05:48.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":437500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third (1/3rd) of the shares subject to the option shall vest on July 20, 2023, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":437500,"derivative":{"exercise_price":4.36,"expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":437500},"source":{"system":"sec-edgar","filing":"0001209191-22-042841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122042841/doc4.xml","form_type":"4"}},{"id":2203929,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:05:48.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Twenty five percent (25%) of the shares subject to the option would have vested on February 1, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option would have vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":9.48,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-22-042841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122042841/doc4.xml","form_type":"4"}},{"id":2203928,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:05:48.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":280000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty five percent (25%) of the shares subject to the option vested on February 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":29.83,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001209191-22-042841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122042841/doc4.xml","form_type":"4"}},{"id":2203927,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-21T20:05:48.000Z","date":"2022-07-20","kind":"disposition_to_issuer","acquired":false,"shares":437500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 20, 2022, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $4.36 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty five percent (25%) of the shares subject to the option vested on April 23, 2021, and one forty-eighth (1/48th) of the shares subject to the option vested each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":437500},"source":{"system":"sec-edgar","filing":"0001209191-22-042841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122042841/doc4.xml","form_type":"4"}},{"id":2256736,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-25T23:00:45.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 23, 2023 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 23, 2025. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":7.77,"expiration_date":"2032-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001567619-22-011718","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000156761922011718/doc1.xml","form_type":"4"}},{"id":2272015,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-13T22:52:01.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":76072,"price":2.8205,"value":214561.076,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 76,072 shares purchased in the price range of $2.79 to $2.93 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":802652,"source":{"system":"sec-edgar","filing":"0001209191-22-028963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122028963/doc4.xml","form_type":"4"}},{"id":2272014,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-13T22:52:01.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":69354,"price":2.7463,"value":190466.8902,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 69,354 shares purchased in the price range of $2.70 to $2.77 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":726580,"source":{"system":"sec-edgar","filing":"0001209191-22-028963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122028963/doc4.xml","form_type":"4"}},{"id":2272013,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-05-13T22:52:01.000Z","date":"2022-05-11","kind":"purchase","acquired":true,"shares":304574,"price":2.901,"value":883569.174,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 304,574 shares purchased in the price range of $2.695 to $2.95 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":657226,"source":{"system":"sec-edgar","filing":"0001209191-22-028963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122028963/doc4.xml","form_type":"4"}},{"id":2317671,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-25T22:42:26.000Z","date":"2022-03-25","kind":"purchase","acquired":true,"shares":50000,"price":4.5434,"value":227170.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $4.455 to $4.60 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":352652,"source":{"system":"sec-edgar","filing":"0001209191-22-021153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122021153/doc4.xml","form_type":"4"}},{"id":2317670,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-25T22:42:26.000Z","date":"2022-03-24","kind":"purchase","acquired":true,"shares":42873,"price":5.0302,"value":215659.7646,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 42,873 shares purchased in the price range of $5.03 to $5.05 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":302652,"source":{"system":"sec-edgar","filing":"0001209191-22-021153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122021153/doc4.xml","form_type":"4"}},{"id":2317669,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-25T22:42:26.000Z","date":"2022-03-23","kind":"purchase","acquired":true,"shares":257127,"price":4.9815,"value":1280878.1505,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 257,127 shares purchased in the price range of $4.73 to $5.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":259779,"source":{"system":"sec-edgar","filing":"0001209191-22-021153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122021153/doc4.xml","form_type":"4"}},{"id":2416629,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-02-02T21:04:06.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-006336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122006336/doc4.xml","form_type":"4"}},{"id":2416628,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T21:04:06.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2023, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":300000,"derivative":{"exercise_price":9.48,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-22-006336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919122006336/doc4.xml","form_type":"4"}},{"id":2567723,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-16T22:17:32.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":3736,"price":25.0612,"value":93628.6432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 3,736 shares sold in the price range of $25.00 to $25.25 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2652,"source":{"system":"sec-edgar","filing":"0001209191-21-056460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121056460/doc4.xml","form_type":"4"}},{"id":2567722,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-16T22:17:32.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":4420,"price":25.0467,"value":110706.414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 4,420 shares sold in the price range of $25.00 to $25.22 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6388,"source":{"system":"sec-edgar","filing":"0001209191-21-056460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121056460/doc4.xml","form_type":"4"}},{"id":2570752,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-14T20:01:22.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":2801,"price":25.0228,"value":70088.8628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 2,801 shares sold in the price range of $25.00 to $25.08 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10808,"source":{"system":"sec-edgar","filing":"0001209191-21-055866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121055866/doc4.xml","form_type":"4"}},{"id":2570751,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-14T20:01:22.000Z","date":"2021-09-10","kind":"sale","acquired":false,"shares":2942,"price":25.0793,"value":73783.3006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 2,942 shares sold in the price range of $25.00 to $25.28 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":13609,"source":{"system":"sec-edgar","filing":"0001209191-21-055866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121055866/doc4.xml","form_type":"4"}},{"id":2574768,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-09T20:33:10.000Z","date":"2021-09-08","kind":"sale","acquired":false,"shares":200,"price":25.035,"value":5007.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $25.00 to $25.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":16551,"source":{"system":"sec-edgar","filing":"0001209191-21-055291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121055291/doc4.xml","form_type":"4"}},{"id":2574767,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-09T20:33:10.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":5981,"price":25.1084,"value":150173.3404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 5,981 shares sold in the price range of $25.00 to $25.295 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":16751,"source":{"system":"sec-edgar","filing":"0001209191-21-055291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121055291/doc4.xml","form_type":"4"}},{"id":2691234,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-28T23:36:51.000Z","date":"2021-05-27","kind":"sale","acquired":false,"shares":400,"price":25.07,"value":10028.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $25.00 to $25.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":22732,"source":{"system":"sec-edgar","filing":"0001209191-21-036686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121036686/doc4.xml","form_type":"4"}},{"id":2698905,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-24T23:27:50.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":12,"price":25,"value":300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":23132,"source":{"system":"sec-edgar","filing":"0001209191-21-035523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121035523/doc4.xml","form_type":"4"}},{"id":2698904,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-24T23:27:50.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":4790,"price":25.1958,"value":120687.882,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 4,790 shares sold in the price range of $25.00 to $25.37 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":23144,"source":{"system":"sec-edgar","filing":"0001209191-21-035523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121035523/doc4.xml","form_type":"4"}},{"id":2698903,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-24T23:27:50.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":2468,"price":25.0664,"value":61863.8752,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 2,468 shares sold in the price range of $25.00 to $25.14 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":27934,"source":{"system":"sec-edgar","filing":"0001209191-21-035523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121035523/doc4.xml","form_type":"4"}},{"id":2705480,"issuer":{"id":2419,"kind":"organization","name":"4D Molecular Therapeutics, Inc.","symbol":"FDMT"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T00:33:45.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatically granted pursuant to the terms of the Company's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable with respect to 1/3 of the total shares on May 17, 2022 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on May 17, 2024. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan)."}],"balance_after":22500,"derivative":{"exercise_price":26.89,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001567619-21-010749","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000156761921010749/doc1.xml","form_type":"4"}},{"id":2708105,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-19T00:17:44.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":200,"price":26.03,"value":5206.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":30402,"source":{"system":"sec-edgar","filing":"0001209191-21-033813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121033813/doc4.xml","form_type":"4"}},{"id":2708104,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-19T00:17:44.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":11132,"price":25.3708,"value":282427.7456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 11,132 shares sold in the price range of $25.00 to $25.93 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30602,"source":{"system":"sec-edgar","filing":"0001209191-21-033813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121033813/doc4.xml","form_type":"4"}},{"id":2708103,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-19T00:17:44.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":2550,"price":25.0526,"value":63884.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 2,550 shares sold in the price range of $25.00 to $25.27 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":41734,"source":{"system":"sec-edgar","filing":"0001209191-21-033813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121033813/doc4.xml","form_type":"4"}},{"id":2708102,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-19T00:17:44.000Z","date":"2021-05-14","kind":"sale","acquired":false,"shares":13896,"price":25.3645,"value":352465.092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 13,896 shares sold in the price range of $25.00 to $25.85 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44284,"source":{"system":"sec-edgar","filing":"0001209191-21-033813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121033813/doc4.xml","form_type":"4"}},{"id":2714462,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-13T23:57:21.000Z","date":"2021-05-13","kind":"sale","acquired":false,"shares":730,"price":25.0425,"value":18281.025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 730 shares sold in the price range of $25.00 to $25.26 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":58180,"source":{"system":"sec-edgar","filing":"0001209191-21-032508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121032508/doc4.xml","form_type":"4"}},{"id":2714461,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-13T23:57:21.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":400,"price":25.024,"value":10009.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $25.00 to $25.04 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":58910,"source":{"system":"sec-edgar","filing":"0001209191-21-032508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121032508/doc4.xml","form_type":"4"}},{"id":2714460,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-13T23:57:21.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":1090,"price":25.2198,"value":27489.582,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 1,090 shares sold in the price range of $25.16 to $25.32 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":59310,"source":{"system":"sec-edgar","filing":"0001209191-21-032508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121032508/doc4.xml","form_type":"4"}},{"id":2734496,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-30T23:56:29.000Z","date":"2021-04-30","kind":"sale","acquired":false,"shares":600,"price":25.2383,"value":15142.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $25.10 to $25.44 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":60400,"source":{"system":"sec-edgar","filing":"0001209191-21-029375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121029375/doc4.xml","form_type":"4"}},{"id":2734495,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-30T23:56:29.000Z","date":"2021-04-28","kind":"sale","acquired":false,"shares":700,"price":25.0596,"value":17541.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 700 shares sold in the price range of $25.00 to $25.12 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":61000,"source":{"system":"sec-edgar","filing":"0001209191-21-029375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121029375/doc4.xml","form_type":"4"}},{"id":2757829,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-05T23:40:25.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":800,"price":25.087,"value":20069.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 800 shares sold in the price range of $25.00 to $25.22 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":61700,"source":{"system":"sec-edgar","filing":"0001209191-21-025492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121025492/doc4.xml","form_type":"4"}},{"id":2885681,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-03T00:29:36.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 1, 2022, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":280000,"derivative":{"exercise_price":29.83,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001209191-21-006962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919121006962/doc4.xml","form_type":"4"}},{"id":3107077,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-17T23:02:46.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the one-year anniversary of the date of grant."}],"balance_after":8500,"derivative":{"exercise_price":65.39,"expiration_date":"2030-06-14","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001209191-20-037414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919120037414/doc4.xml","form_type":"4"}},{"id":3168410,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series C Preferred Stock","published_at":"2020-04-28T21:06:38.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-20-025981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919120025981/doc4.xml","form_type":"4"}},{"id":3168409,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-28T21:06:38.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date."}],"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001209191-20-025981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919120025981/doc4.xml","form_type":"4"}},{"id":3169276,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-27T20:37:44.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter."}],"balance_after":437500,"derivative":{"exercise_price":16,"expiration_date":"2030-04-22","underlying":"Common Stock","underlying_shares":437500},"source":{"system":"sec-edgar","filing":"0001209191-20-025801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919120025801/doc4.xml","form_type":"4"}},{"id":3550099,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-24T22:02:38.000Z","date":"2019-04-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will become fully vested on the date of the Issuer's 2020 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":27.06,"expiration_date":"2029-04-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-025788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919119025788/doc4.xml","form_type":"4"}},{"id":4066209,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:28:06.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-009139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919118009139/doc4.xml","form_type":"4"}},{"id":4066208,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:28:06.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":25200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":6.58,"expiration_date":"2025-01-07","underlying":"Common Stock","underlying_shares":25200},"source":{"system":"sec-edgar","filing":"0001209191-18-009139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919118009139/doc4.xml","form_type":"4"}},{"id":4066207,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-12T20:28:06.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":7.4,"expiration_date":"2024-05-29","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-18-009139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919118009139/doc4.xml","form_type":"4"}},{"id":4066206,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-12T20:28:06.000Z","date":"2018-02-08","kind":"disposition_to_issuer","acquired":false,"shares":70572,"price":27,"value":1905444.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the acquisition of the Issuer by Roche Holdings, Inc. (\"Parent\") on February 8, 2018, and pursuant to the terms of the Agreement and Plan of Merger by and among the Issuer, Parent and Abingdon Acquisition Corp. (\"Merger Sub\") dated December 21, 2017, Merger Sub acquired all of the issued and outstanding shares of Common Stock (the \"Shares\") for a purchase price of $27.00 per Share (the \"Merger\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-009139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919118009139/doc4.xml","form_type":"4"}},{"id":4105548,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-06T01:09:25.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest as to 25% of the shares underlying each award on each anniversary of the Grant Date, subject to the Reporting Person's continues service with the Company through the vesting date."}],"balance_after":70572,"source":{"system":"sec-edgar","filing":"0001209191-18-002592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919118002592/doc4.xml","form_type":"4"}},{"id":4122471,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-23T02:44:24.000Z","date":"2017-12-22","kind":"grant","acquired":true,"shares":23334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest as to 25% of the shares underlying each award on each anniversary of the Grant Date, subject to the Reporting Person's continues service with the Company through the vesting date."}],"balance_after":66172,"source":{"system":"sec-edgar","filing":"0001209191-17-067159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919117067159/doc4.xml","form_type":"4"}},{"id":4496492,"issuer":{"id":169521,"kind":"organization","name":"Ignyta, Inc.","symbol":"RXDX"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-06T23:45:02.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests.  25% of the shares subject to the option vest on January 5, 2018, and 1/48th of the shares subject to the option vest monthly thereafter."}],"balance_after":50000,"derivative":{"exercise_price":5.6,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-002761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000120919117002761/doc4.xml","form_type":"4"}}]}